THE ARAB DRUG COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.19 EGP | 0.00% |
|
0.00% | +35.27% |
| Sales 2022 | 505M 10.58M 846M | Sales 2023 | 634M 13.28M 1.06B | Capitalization | 401M 8.41M 672M |
|---|---|---|---|---|---|
| Net income 2022 | 76M 1.59M 127M | Net income 2023 | 82M 1.72M 137M | EV / Sales 2022 | 0.76 x |
| Net Debt 2022 | 111M 2.32M 186M | Net Debt 2023 | 142M 2.97M 237M | EV / Sales 2023 | 0.86 x |
| P/E ratio 2022 |
4.07
x | P/E ratio 2023 |
5.64
x | Employees | 1,148 |
| Yield 2022 * |
-
| Yield 2023 |
6.73% | Free-Float | 25.15% |
More Fundamentals
* Assessed data
More news
| Current month | +1.42% | ||
| 1 month | +0.18% | ||
| 3 months | +19.50% | ||
| 6 months | +50.73% | ||
| Current year | +35.27% |
1 week
84.10
91.50
1 month
84.1098.00
Current year
70.2298.00
1 year
55.0098.00
3 years
41.0098.00
5 years
26.3198.00
10 years
5.4598.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Executive Officer | - | - | |
Tariq Ali
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Investor Relations Contact | - | - | |
| Chief Executive Officer | - | - | |
| Chairman | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/04/24 | 94.19 | 0.00% | 121 |
| 24/04/24 | 94.19 | 0.00% | 391 |
| 23/04/24 | 94.19 | 0.00% | 1,225 |
| 22/04/24 | 94.19 | 0.00% | 96 |
End-of-day quote Egyptian Exchange, April 27, 2024
More quotes
Arab Drug Company for Pharmaceuticals and Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical and veterinary products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +35.27% | 11.8M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- ADCI Stock
